Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.
As part of Deepbridge's continuing growth, we are delighted to introduce 3 new members of the team! All come with a wealth of experience in their respective field and add further value and expertise to the Deepbridge team.
Ian Warwick (Deepbridge Capital - Managing Partner) commented:
Deepbridge can confirm that the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS have capacity for deployment prior to 5 April 2018. With rumours abounding of limited capacity this tax year, the Deepbridge Technology Growth EIS and Deepbridge Life Sciences EIS provide advisers and investors with access to a portfolio of innovation driven companies, with deployment this Tax Year*.
Zilico, part of the Deepbridge Technology Growth EIS portfolio, has secured investments totaling around $19 million (around £13.7 million). As part of this investment, Deepbridge has contributed £3 million of this, with other backers including MaxHealth Medicine Group. Deepbridge is now in discussion with Zilico regarding a further fund raise.
Zilico intends to use the funds to continue its global expansion plans for ZedScan™ across the UK, Europe, and China and take the product through its regulatory trials in the US.
Deepbridge is delighted to have signed up to support the ‘Colours For Peace’ initiative on 20 March 2018, and we urge other companies to join us.
20th March 2018 will represent the 25th Anniversary of the IRA’s bombing of Warrington and the deaths of 3 year-old Johnathan Ball and 12 year-old Tim Parry.
